United States

Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

10:20am EDT
Change (% chg)

$-0.16 (-0.56%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for GHDX.O


Genomic Health, Inc. is a healthcare company, which provides genomic-based diagnostic tests for the treatment of early stage cancer. The Company offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene... (more)


Beta: 0.49
Market Cap(Mil.): $948.53
Shares Outstanding(Mil.): 33.02
Dividend: --
Yield (%): --


  GHDX.O Industry Sector
P/E (TTM): -- 41.55 39.69
EPS (TTM): -0.93 -- --
ROI: -20.13 -9.57 14.44
ROE: -20.51 -9.91 15.49

BRIEF-Genomic Health increased number of board members on June 21

* On June 21, 2016 board increased the authorized number of members of the board of directors of the company to eight Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 23 2016

BRIEF-Genomic Health reports Q1 loss per share of $0.19

* Reports double-digit revenue and test growth in announcement of first quarter 2016 financial results

May 04 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
Provider : New Constructs, LLC
Provider : Thomson Reuters Stock Report
Provider : Wright Reports
Provider : ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.